English

GLP-1 Agonists: CV Outcomes Data in Type 2 Diabetes

Published 2019-06-12

Download video

Download video MP4 360p

Recommendations

09:43

The Story of GLP-1. "A diabetes doctor’s dream". Episode 1
05:22

Understanding the Role of GLP-1 Medicines in Managing Type 2 Diabetes
13:54

Using GLP1 receptor agonists to treat cardiac patients with diabetes
02:51

Jeffrey Berger, MD: Deciding Between GLP1 Agonists or SGLT2 Inhibitors
1:13:00

Current Treatment Practices for Schizophrenia Spectrum Disorders
02:09

Dr Darren K. McGuire Discusses Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in T2D
08:09

Novel CSA Treatments with M. Safwan Badr, MD
04:38

How does sitagliptin work? DPP-4 inhibitors and GLP-1 mimetics
21:44

Dr. Paul Mason - 'The corrupt history of the food pyramid'
47:52

What is GLP-1, What Does It Do, and Where Does It Come From? with Dr. Ben Bikman
08:32

How Does Metformin Work? (Pharmacology for Nurses)
08:43

Advancements in Pediatric Psoriasis Treatment, with Lisa Swanson, MD
20:05

Dr. Paul Mason - 'The shady truth about statins'
01:32

How GLP-1 medications help you lose weight
05:09

Edward V Loftus, Jr, MD: Discussing FDA Approval of Risankizumab (Skyrizi) in Ulcerative Colitis
24:10

Dr. Maryanne Demasi - 'Statin Wars: Have we been misled by the evidence?'
03:55

MASH Management in Women
10:00

Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
48:11

Brain Energy, Mitochondria, and Mental Health with Dr. Chris Palmer

Similar videos

07:17

Cardiovascular Outcomes With GLP-1 Receptor Agonists in Type 2 Diabetes
05:05

SGLT2 Inhibitors: CV Outcomes Data in Type 2 Diabetes
39:11

Exploring Advances in GLP-1 Agonist Therapy
44:17

Cardiovascular Disease Burden in Type 2 Diabetes: Strategies to Improve Outcomes
1:29:07

Optimizing Cardiovascular Outcomes in Type 2 Diabetes: Beyond A1C Goals
58:42

Type 2 Diabetes: New Guidelines and Controversies
06:11

Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists
08:49

Mechanisms of Action of GLP-1 Agonists in T2D
04:47

GLP-1 Receptor Agonists and Cardiovascular Benefit
03:50

Diabetes Drugs for Cardiovascular Risk
1:02:44

Exploring the Science and Practice of GLP-1 Receptor Agonists
40:56

Cardiovascular and Renal Outcomes in Type 2 Diabetes Medications with Dr. Marie McDonnell
50:30

Protocols for Safe Use of SGLT2i and GLP1RA in the Hospital Setting